Abbott Laboratories acquired Exact Sciences, a company specializing in cancer diagnostics, in a move that also involved competition in the medical device market.
9 reports, 3 independent
Updated Aug 26
Gone quiet
- Reports
- 9
- Developments
- 3
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Abbott Laboratories acquired Exact Sciences, a company specializing in cancer diagnostics, in a move that also involved competition in the medical device market.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Exact Sciences stock lags the broader market index following the acquisition by Abbott.1 source
Analyst targets and CEO outlook detail the market reaction to the Abbott/Exact Sciences acquisition.1 source
Abbott Laboratories acquired Exact Sciences for cancer diagnostics.1 source
Keep exploring
The entities involved
-
Abbott Laboratories
American global health care and medical device products company
-
Exact Sciences
American company in Madison, United States
Related events
- Intuitive Surgical, Boston Scientific, and Abbott Laboratories are major players in the global healthcare device sector.
- Medtronic plc, Intuitive Surgical, Inc., and Abbott Laboratories are leaders in medical device technology and are currently facing market valuation pressures.
- Abbott Laboratories' medical devices business is driving segment growth while pursuing a major $21 billion acquisition.
- AbbVie, Abbott Laboratories, and Johnson & Johnson were recommended as dividend stocks for retirees, operating in the healthcare sector.